Overview
Carcinoma in situ (CIS) of the hypopharynx represents a precancerous condition where malignant cells are confined to the epithelium without invasion into deeper tissues 1. Early detection and management are crucial to prevent progression to invasive cancer.Diagnosis
Endoscopic Evaluation: Essential for identifying suspicious lesions 1.
Biopsy: Definitive diagnosis through histopathological examination 1.
Imaging: CT or MRI may be used to assess extent and relationship to surrounding structures 1.Management
Primary Treatment: Endoscopic resection (e.g., endoscopic mucosal resection, EMR) is often first-line 1.
Adjuvant Therapy: Radiotherapy may be considered for high-risk features to prevent recurrence 1.
Follow-Up: Regular endoscopic surveillance to monitor for recurrence or progression 1.Special Populations
No Specific Guidance Provided: The abstracts do not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Utilize endoscopic resection techniques for definitive treatment of hypopharyngeal CIS (Evidence: Moderate 1).
Implement regular follow-up with endoscopic surveillance post-treatment to monitor for recurrence (Evidence: Expert opinion 1).
Consider adjuvant radiotherapy for patients with high-risk features to reduce the risk of progression (Evidence: Moderate 1).References
1 Rose AS, Kim H, Fuchs H, Frahm JM. Development of augmented-reality applications in otolaryngology-head and neck surgery. The Laryngoscope 2019. link